Bleakley Financial Group LLC Lowers Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Bleakley Financial Group LLC reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 6.1% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 24,094 shares of the healthcare conglomerate's stock after selling 1,576 shares during the quarter. Bleakley Financial Group LLC's holdings in UnitedHealth Group were worth $12,188,000 at the end of the most recent reporting period.

Several other institutional investors also recently added to or reduced their stakes in UNH. AMF Tjanstepension AB boosted its stake in UnitedHealth Group by 88.0% in the third quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate's stock worth $151,374,000 after purchasing an additional 121,180 shares in the last quarter. Hudson Value Partners LLC grew its holdings in shares of UnitedHealth Group by 8.3% during the third quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate's stock worth $625,000 after buying an additional 82 shares in the last quarter. Brookstone Capital Management boosted its position in UnitedHealth Group by 6.7% during the third quarter. Brookstone Capital Management now owns 24,289 shares of the healthcare conglomerate's stock valued at $14,201,000 after purchasing an additional 1,529 shares during the last quarter. Hoxton Planning & Management LLC boosted its position in UnitedHealth Group by 30.8% during the third quarter. Hoxton Planning & Management LLC now owns 1,512 shares of the healthcare conglomerate's stock valued at $884,000 after purchasing an additional 356 shares during the last quarter. Finally, Rockingstone Advisors LLC acquired a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $291,000. 87.86% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several analysts recently weighed in on the company. UBS Group dropped their price target on UnitedHealth Group from $680.00 to $650.00 and set a "buy" rating for the company in a report on Wednesday, October 16th. Royal Bank of Canada decreased their price target on UnitedHealth Group from $615.00 to $595.00 and set an "outperform" rating on the stock in a research note on Wednesday, October 16th. Bank of America reduced their price objective on UnitedHealth Group from $675.00 to $650.00 and set a "buy" rating on the stock in a research report on Wednesday, October 16th. Stephens lifted their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an "overweight" rating in a report on Thursday, December 5th. Finally, Hsbc Global Res raised UnitedHealth Group from a "hold" rating to a "strong-buy" rating in a research report on Friday, January 10th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, UnitedHealth Group has an average rating of "Buy" and a consensus price target of $629.32.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the business's stock in a transaction on Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company's stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.33% of the company's stock.

UnitedHealth Group Price Performance

Shares of UNH traded down $10.11 during midday trading on Thursday, hitting $529.71. 3,924,803 shares of the company traded hands, compared to its average volume of 4,447,235. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The firm has a 50 day moving average of $532.43 and a 200-day moving average of $564.77. The stock has a market cap of $487.48 billion, a price-to-earnings ratio of 34.17, a PEG ratio of 1.48 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company's quarterly revenue was up 6.8% compared to the same quarter last year. During the same period last year, the company posted $5.83 earnings per share. On average, analysts forecast that UnitedHealth Group Incorporated will post 29.63 EPS for the current fiscal year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.